Krilogy Financial LLC increased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 107.8% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,966 shares of the company’s stock after purchasing an additional 1,539 shares during the quarter. Krilogy Financial LLC’s holdings in HCA Healthcare were worth $1,433,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also made changes to their positions in HCA. Norges Bank purchased a new position in HCA Healthcare in the fourth quarter worth approximately $1,262,513,000. Life Cycle Investment Partners Ltd acquired a new stake in shares of HCA Healthcare in the 4th quarter valued at $374,037,000. Viking Global Investors LP grew its stake in shares of HCA Healthcare by 58.5% during the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after purchasing an additional 690,773 shares in the last quarter. Northwestern Mutual Wealth Management Co. raised its stake in HCA Healthcare by 4,545.5% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 663,337 shares of the company’s stock valued at $309,686,000 after buying an additional 649,058 shares in the last quarter. Finally, Danske Bank A S purchased a new position in shares of HCA Healthcare in the 3rd quarter valued at about $115,530,000. 62.73% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several equities research analysts recently weighed in on HCA shares. Barclays decreased their target price on HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating for the company in a research note on Monday, April 27th. Argus reduced their price target on shares of HCA Healthcare from $560.00 to $500.00 and set a “buy” rating for the company in a research report on Monday, May 4th. KeyCorp decreased their target price on HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating for the company in a research report on Monday, April 27th. Oppenheimer decreased their price objective on HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating for the company in a report on Monday, April 27th. Finally, Robert W. Baird lowered their price objective on shares of HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 15th. Fifteen analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $503.00.
HCA Healthcare Stock Down 0.2%
Shares of NYSE:HCA opened at $387.14 on Friday. The company has a market cap of $85.88 billion, a P/E ratio of 13.31, a PEG ratio of 1.23 and a beta of 1.12. The company has a 50-day moving average price of $410.50 and a 200 day moving average price of $465.84. HCA Healthcare, Inc. has a 52 week low of $330.00 and a 52 week high of $556.52.
HCA Healthcare (NYSE:HCA – Get Free Report) last posted its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The business had revenue of $19.11 billion during the quarter, compared to analysts’ expectations of $19.09 billion. During the same quarter last year, the firm earned $6.45 earnings per share. The firm’s quarterly revenue was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Analysts expect that HCA Healthcare, Inc. will post 30.07 EPS for the current year.
HCA Healthcare Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be issued a $0.78 dividend. The ex-dividend date of this dividend is Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. HCA Healthcare’s dividend payout ratio (DPR) is 10.73%.
HCA Healthcare Company Profile
HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Further Reading
- Five stocks we like better than HCA Healthcare
- MDA Space Targets US Defense Market With $620M Acquisition
- Carnival’s Second Quarter: Is the Stock Still Complicated?
- Domino’s Stock Slides to 52-Week Low as Investors Digest CEO Change
- Microsoft Solves AI’s Biggest Bottleneck With Chevron Deal
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
